Guidelines for the pharmacological treatment of anxiety disorders,
obsessive–compulsive disorder and posttraumatic stress disorder
in primary care
BORWIN BANDELOW1, LEO SHER2, ROBERTAS BUNEVICIUS3, ERIC HOLLANDER2,
SIEGFRIED KASPER4, JOSEPH ZOHAR5, HANS-JÜRGEN MÖLLER6, WFSBP TASK
FORCE ON MENTAL DISORDERS IN PRIMARY CAREa AND WFSBP TASK FORCE ON
ANXIETY DISORDERS, OCD AND PTSDb
1Department
of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany, 2Albert Einstein College of
Medicine and Montefiore Medical Center, New York City, NY, USA, 3Institute of Psychophysiology and Rehabilitation,
Lithuanian University of Health Sciences, Palanga, Lithuania, 4Department of Psychiatry and Psychotherapy, Medical
University of Vienna,Vienna, Austria, 5Division of Psychiatry, Chaim-Sheba Medical Center, Tel-Hashomer, Ramat Gan,
Israel, and 6Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany
Abstract
Objective.